Literature DB >> 22218201

A preliminary examination of prolonged exposure therapy with Iraq and Afghanistan veterans with a diagnosis of posttraumatic stress disorder and mild to moderate traumatic brain injury.

Gregory K Wolf1, Thad Q Strom, Shannon M Kehle, Afsoon Eftekhari.   

Abstract

OBJECTIVE: : Preliminary examination of the effectiveness of prolonged exposure (PE) therapy for the treatment of posttraumatic stress disorder (PTSD) with Operation Enduring Freedom and Operation Iraqi Freedom Veterans who have experienced traumatic brain injury (TBI). PARTICIPANTS: : Ten Veterans with a history of mild to moderate TBI and chronic PTSD.
SETTING: : Outpatient Mental Health/PTSD clinics and polytrauma centers at 2 VA medical centers. MEASURES: : Comprehensive evaluation that included clinical interview, neuropsychologic evaluation, and/or neuroimaging; Posttraumatic Stress Disorder Checklist and Beck Depression Inventory-Second Edition. PROCEDURES: : Standard implementation of the PE manual was used in all cases with slight adjustments to account for Veterans' residual cognitive deficits. Veterans completed between 8 and 18 sessions.
RESULTS: : Veterans demonstrated significant reductions in total PTSD and depression symptoms from pre- to posttreatment. Within-group effect sizes were large.
CONCLUSIONS: : These findings suggest that PE can be safely and effectively implemented with Veterans with PTSD, a history of mild to moderate TBI, and current cognitive impairment.

Entities:  

Mesh:

Year:  2012        PMID: 22218201     DOI: 10.1097/HTR.0b013e31823cd01f

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  8 in total

1.  Hyperbaric oxygen therapy for post-concussion syndrome: contradictory conclusions from a study mischaracterized as sham-controlled.

Authors:  Paul G Harch
Journal:  J Neurotrauma       Date:  2013-10-11       Impact factor: 5.269

2.  A non-inferiority trial of Prolonged Exposure for posttraumatic stress disorder: In person versus home-based telehealth.

Authors:  Ron Acierno; Rebecca Knapp; Peter Tuerk; Amanda K Gilmore; Carl Lejuez; Kenneth Ruggiero; Wendy Muzzy; Leonard Egede; Melba A Hernandez-Tejada; Edna B Foa
Journal:  Behav Res Ther       Date:  2016-11-22

3.  Chronic Pain, TBI, and PTSD in Military Veterans: A Link to Suicidal Ideation and Violent Impulses?

Authors:  Shannon M Blakey; H Ryan Wagner; Jennifer Naylor; Mira Brancu; Ilana Lane; Meghann Sallee; Nathan A Kimbrel; Eric B Elbogen
Journal:  J Pain       Date:  2018-03-08       Impact factor: 5.820

Review 4.  Evaluation of post-traumatic stress disorder (PTSD) and related comorbidities in clinical studies.

Authors:  Ioana Anamaria Mureșanu; Diana Alecsandra Grad; Dafin Fior Mureșanu; Stefana-Andrada Dobran; Elian Hapca; Ștefan Strilciuc; Irina Benedek; David Capriș; Bogdan Ovidiu Popescu; Lăcrămioara Perju-Dumbravă; Răzvan Mircea Cherecheș
Journal:  J Med Life       Date:  2022-04

Review 5.  Managing behavioral health needs of veterans with traumatic brain injury (TBI) in primary care.

Authors:  Paul R King; Laura O Wray
Journal:  J Clin Psychol Med Settings       Date:  2012-12

Review 6.  Emotion Dysregulation Following Trauma: Shared Neurocircuitry of Traumatic Brain Injury and Trauma-Related Psychiatric Disorders.

Authors:  Carissa N Weis; E Kate Webb; Terri A deRoon-Cassini; Christine L Larson
Journal:  Biol Psychiatry       Date:  2021-07-31       Impact factor: 13.382

Review 7.  Psychological Intervention in Traumatic Brain Injury Patients.

Authors:  Lizzette Gómez-de-Regil; Damaris F Estrella-Castillo; Julio Vega-Cauich
Journal:  Behav Neurol       Date:  2019-05-02       Impact factor: 3.342

8.  Baseline Cognitive Performance and Treatment Outcomes From Cognitive-Behavioral Therapies for Posttraumatic Stress Disorder: A Naturalistic Study.

Authors:  Kaloyan S Tanev; Lydia E Federico; Mark S Greenberg; Scott P Orr; Elizabeth M Goetter; Patricia A Resick; Roger K Pitman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-01-17       Impact factor: 2.198

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.